Related Experiment Videos
Recurrent primary biliary cirrhosis after liver transplantation
M G Silveira1, J A Talwalkar1,2, K D Lindor1
1Miles and Shirley Fitterman Center for Digestive Diseases.
Summary
Recurrent primary biliary cirrhosis (PBC) after liver transplantation (LT) occurs in 9-35% of patients, diagnosed by histology. Early treatment with ursodeoxycholic acid may help, but long-term survival requires further study.
Area of Science:
- Hepatology
- Transplantation Medicine
- Immunology
Background:
- Recurrent primary biliary cirrhosis (rPBC) is a significant complication following liver transplantation (LT).
- Prevalence of rPBC varies widely (9-35%) across transplant centers.
- Histologic evidence of granulomatous changes is the primary diagnostic criterion for rPBC.
Purpose of the Study:
- To review the prevalence, diagnosis, risk factors, and outcomes of recurrent primary biliary cirrhosis after liver transplantation.
- To highlight the diagnostic challenges and potential therapeutic strategies for rPBC.
Main Methods:
- Literature review of studies on recurrent primary biliary cirrhosis post-liver transplantation.
- Analysis of diagnostic hallmarks, clinical presentation, and risk factors.
- Evaluation of treatment options and patient outcomes.
Main Results:
- Histology is crucial for diagnosing rPBC, as clinical and biochemical markers are often absent.
- Potential risk factors include recipient (age, gender, HLA, immunosuppression) and donor (age, gender, ischemic time) characteristics, though evidence is debated.
- Most patients are diagnosed with early-stage disease, and ursodeoxycholic acid may be beneficial.
Conclusions:
- Recurrent primary biliary cirrhosis presents diagnostic challenges due to non-specific clinical and biochemical findings.
- While short- to medium-term outcomes post-LT for rPBC are generally favorable, long-term graft and patient survival warrant continued investigation.
- Further research is needed to clarify risk factors and optimize management strategies for rPBC.
Related Concept Videos
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...